Expression levels of the β2-M protein are significantly different in the four breast cancer molecular subtypes, significant differences were demonstrated between the ER+ and ER− breast cancer groups, but not between the HER-2+ and HER-2− breast cancer groups. This evidence concerns the gene ERBB2 and breast carcinoma.